Covered recipient · General Payments record
MUZAFFAR IQBAL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$1,501.99
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $374.10 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $160.84 | 18 |
| ABBVIE INC. | $54.35 | 2 |
| Janssen Biotech, Inc. | $34.59 | 1 |
| Astellas Pharma US Inc | $31.35 | 1 |
| E.R. Squibb & Sons, L.L.C. | $27.60 | 2 |
| Genentech USA, Inc. | $24.60 | 1 |
| Celgene Corporation | $23.39 | 1 |
| Stemline Therapeutics Inc. | $17.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.11 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969023 | CMS |
| ABBVIE INC. | $23.24 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969025 | CMS |
| Astellas Pharma US Inc | $31.35 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139427528 | CMS |
| Celgene Corporation | $23.39 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101118363 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101360410 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.55 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101360438 | CMS |
| Genentech USA, Inc. | $24.60 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133077118 | CMS |
| Janssen Biotech, Inc. | $34.59 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078638702 | CMS |
| PFIZER INC. | $3.05 | 01/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130896304 | CMS |
| PFIZER INC. | $11.64 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130897540 | CMS |
| PFIZER INC. | $3.69 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131293369 | CMS |
| PFIZER INC. | $1.78 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131323975 | CMS |
| PFIZER INC. | $15.51 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131324255 | CMS |
| PFIZER INC. | $0.62 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131325960 | CMS |
| PFIZER INC. | $1.15 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131248730 | CMS |
| PFIZER INC. | $18.97 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131834390 | CMS |
| PFIZER INC. | $0.56 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243905 | CMS |
| PFIZER INC. | $16.26 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131903119 | CMS |
| PFIZER INC. | $10.46 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130937528 | CMS |
| PFIZER INC. | $13.39 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131376644 | CMS |
| PFIZER INC. | $3.67 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131378897 | CMS |
| PFIZER INC. | $21.50 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243909 | CMS |
| PFIZER INC. | $16.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131392056 | CMS |
| PFIZER INC. | $4.67 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131388723 | CMS |
| PFIZER INC. | $13.54 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131390485 | CMS |
| PFIZER INC. | $4.28 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131388066 | CMS |
| Stemline Therapeutics Inc. | $17.38 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142962481 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.